GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovid Therapeutics Inc (STU:1OT) » Definitions » Non Operating Income

Ovid Therapeutics (STU:1OT) Non Operating Income : €29.17 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Ovid Therapeutics Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Ovid Therapeutics's Non Operating Income for the three months ended in Dec. 2024 was €-2.37 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 was €29.17 Mil.

Ovid Therapeutics Non Operating Income Historical Data

The historical data trend for Ovid Therapeutics's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovid Therapeutics Non Operating Income Chart

Ovid Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 -0.04 1.30 1.83 30.08

Ovid Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.90 5.27 26.98 -0.70 -2.37

Ovid Therapeutics Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €29.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ovid Therapeutics Non Operating Income Related Terms

Thank you for viewing the detailed overview of Ovid Therapeutics's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovid Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovid Therapeutics Inc (STU:1OT) » Definitions » Non Operating Income
Comparable Companies
PULM CVM MLEC CARA CDIO TENX NRSN CLGN IGC ASBP VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
OVID:USA
Address
441 Ninth Avenue, 14th Floor, New York, NY, USA, 10001
Website
https://www.ovidrx.com
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

Ovid Therapeutics Headlines

No Headlines